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Abstract 
Jembrana disease virus (JDV) is an acutely pathogenic lentivirus affecting Bali cattle in 
Indonesia.  The inability to propagate the virus in vitro has made it difficult to quantitate 
JDV and determine the kinetics of virus replication during the acute disease process. 
Reported for the first time are 2 techniques that enable quantification of the virus, and 
the use of these techniques to quantify the virus load in plasma of cattle during the 
acute disease process.  The 2 techniques were a qualitative one-step JDV real-time 
reverse-transcription polymerase chain reaction (qRT-PCR) assay for the detection 
and quantification of JDV RNA, and a JDV p26 capture ELISA for the detection and 
quantification of JDV capsid protein.  The limit of detection of the qRT-PCR was 9.8 x 
10
2 JDV viral RNA copies over 35 cycles, equivalent to 4.2 x 10
4 JDV genome 
copies/ml, and a peak virus load of 1.6 x 10
12 JDV genome copies /ml during the acute 
febrile period.  Viral RNA and JDV p26 levels were correlated in 48 plasma samples 
obtained from experimentally infected cattle.  A significant positive correlation (R = 
0.835 and r
2 = 0.697) was observed between the 2 techniques within the range of their 
detection limits, providing a solid basis for the use of the economical capture ELISA to 
quantify JDV load when real-time PCR capability is not available.  The detection of 
JDV p26 by capture ELISA was, however, much less sensitive than the real-time RT-
PCR with a detection limit equating to approximately 1 x 10
8 JDV genome copies/ml. 
The transcriptional pattern of JDV during the acute phase of infection was studied by 
RT-PCR, sequencing and northern blot analysis.  Analysis revealed a complex pattern 
of transcription with the identification of 14 transcripts, which confirmed 6 predicted 
splice sites and the identified 7 splice sites not reported previously.  A small 78 bp 
putative non-coding exon was identified that shared the same splice acceptor as vif 
and was associated with the alternative transcripts of tat, rev and env.  Four tat, 3 rev 
and 2 env transcripts were identified.  The rev and env transcripts were demonstrated 
to use the same splice site.  The study confirmed that the production of a tmx 
transcript, a unique gene identified in the two bovine lentiviruses JDV and Bovine 
immunodeficiency virus (BIV).  Northern blot analysis identified 11 of the 14 transcripts 
identified by RT-PCR, including a 7.8 kb gag/pol primary transcript and singly spliced 
transcripts.  The complexity of the transcript map produced suggested that JDV 
replication is a highly regulated process. 
One of the aims of this thesis was to determine the functional role of the Tmx and Vif 
accessory proteins of the bovine lentiviruses.  Although this aim was not achieved, 
molecular reagents were produced that will allow these investigations to proceed.  The   iv
Vif and Tmx proteins of both JDV and BIV were successfully expressed as C-terminal 
fusions with glutathione S-transferase (GST) using the pGEX-6P-1 bacterial 
expression system.  The recombinant proteins were purified and were recognised by 
both BIV and JDV antisera from Bos taurus and Bos javanicus respectively, and by 
antibody in sera from cattle that had been vaccinated with a tissue-derived JDV 
vaccine and also those that had been naturally infected with JDV.  The Vif, Tmx and 
Rev proteins of JDV and vif BIV were successfully expressed in a Rev-independent 
manner in COS7 and bovine macrophage cells using a pcDNA3.1
® mammalian 
expression system.  Cellular localisation of the recombinant viral proteins varied in the 
2 cell types: in COS7 cells, both JDV and BIV Vif were detected predominantly in the 
nucleus, whereas in bovine macrophage cells BIV Vif localised in the cytoplasm and 
JDV Vif localised in the cytoplasm and nuclear membrane.  JDV Tmx localised in the 
cytoplasm of COS7 cells but the nuclear membrane of bovine macrophage cells, and 
BIV Tmx localised in the nucleus and nuclear membrane in both cell types and 
appeared to affect the morphology of the nucleus.  Mutations of vif and tmx were also 
successfully engineered into an infectious clone of BIV and these mutated clones will 
provide a valuable resource for further investigation of the role of Vif and Tmx in 
replication of the bovine lentiviruses.    v
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